U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07111884) titled 'GMMG Multiple Myeloma Registry' on July 30, 2024.
Brief Summary: The goal of this observational study is to collect long-term clinical follow-up data on patients with multiple myeloma who participated in a therapy study of the German-Speaking Myeloma Multicenter Group (GMMG). Target variables of interest are:
Overall survival, progression-free survival and follow-up time.
The relevant registry data will be provided and evaluated together with the therapy study data for scientific research projects.
This allows seamless documentation of patient data from the end of the trial to long-term follow-up.
Study Start Date: Dec. 08, 2022...